COVID-19 Vaccination Policy Debate Continues
The COVID-19 pandemic may be behind us, but debates around vaccination persist. Recently, Health and Human Services Secretary Robert F. Kennedy Jr. stirred controversy with his updated vaccine policy, facing backlash for being, as some critics put it, “irresponsible.”
Kennedy’s team has shifted focus away from the Biden administration’s emphasis on universal COVID-19 vaccinations. They are now prioritizing booster shots for older Americans and those who are at greater risk of severe illness, hospitalization, and death.
In August 2025, the Food and Drug Administration approved the COVID-19 vaccine for all individuals aged 65 and above and for younger people aged 5 to 64 with underlying health conditions.
Interestingly, Kennedy’s team is no longer advocating routine vaccinations for healthy children and pregnant women. Back in May, FDA Commissioner Dr. Marty Makary also announced new clinical trials to assess the necessity of annual boosters for healthy individuals aged six months to 64 years. Critics might disagree, but collecting and analyzing more data seems reasonable; after all, science is a constantly evolving field.
It’s worth noting that many of our European allies have adopted similar strategies. The “universalist” vaccination approach previously pushed by the Biden administration has rendered the U.S. somewhat of an anomaly among economically developed nations.
As Kennedy works to realign the American vaccination approach with that of Europe, his detractors seem to imply that leading medical experts in sophisticated health systems are somehow “anti-vax” or lacking responsibility.
In reality, European policies lean towards the view that continued COVID-19 immunization should be concentrated on the elderly and immunocompromised. For instance, in 2025, the United Kingdom’s Joint Committee on Vaccination and Immunization recommended focusing COVID-19 vaccination efforts on high-risk groups instead of a blanket booster campaign.
The British guidelines state that COVID-19 vaccinations are targeted at adults aged 75 and older, immunocompromised persons, and residents in care homes. Likewise, Denmark has similar vaccine guidelines, as do Sweden and Italy.
In France, while COVID-19 vaccination is available to everyone on a voluntary basis, boosters are particularly recommended for those over 80, nursing home residents, and anyone who is immunocompromised due to other health issues. Meanwhile, Germany’s health ministry advises boosters for individuals aged 60 and older, as well as nursing home residents and those with underlying conditions.
Importantly, German authorities do not advocate COVID-19 vaccination for babies, children, or adolescents without underlying medical conditions. The World Health Organization has also recognized that ongoing vaccination efforts are most beneficial for high-risk groups.
It might be beneficial for Congressional investigators to consult with European public health experts to understand why they have transitioned to more focused COVID-19 vaccine strategies, possibly shedding light on the U.S. debates.
At this moment, children—especially vulnerable infants—have become focal points in the ongoing vaccine discussions. This is largely due to a leaked memo from Dr. Vinay Prasad, the director at the FDA, which suggested that FDA career analysts found that, between 2021 and 2024, at least 10 children among 96 reported deaths may have died from the COVID-19 vaccine.
This memo ignited considerable debate, leading to strong criticism. In a response published in The New England Journal of Medicine, several former FDA Commissioners challenged Prasad’s findings, arguing that they undermine medical innovation and public health safety. They emphasize that the COVID-19 vaccines are safe for children and that the Vaccine Adverse Event Reporting System lacks crucial clinical data, making allegations of vaccine-related childhood mortality irresponsible.
They have a point about the shortcomings of the VAERS database. Congressional inquiries have also established that VAERS is unreliable, as anyone can submit reports and none are scientifically validated. Just because an event is reported doesn’t mean it’s caused by the vaccine.
That said, while the critics are correct about VAERS limitations, it’s important to consider that it recorded over 1.8 million adverse events between 2020 and 2024, including over 38,000 deaths linked to COVID-19 vaccinations. Given those numbers and ongoing reports of adverse reactions, the FDA should thoroughly investigate the ten child fatalities. Even platforms like The Atlantic acknowledge the possibility of vaccine-associated child deaths.
Clarity is essential for the public. They have faced years of mixed messages, illegal attempts to enforce vaccine mandates, and misleading claims about the vaccines’ effectiveness, not to mention the lack of warnings regarding myocarditis risks in younger populations.
Interestingly, many of those who defended the previous administration’s policies are now amongst Kennedy’s fiercest critics. It’s worth remembering that they played a role in eroding public trust. It’s a complicated landscape, to say the least.
